EdgarLookup

Morgan Stanley Direct Lending Fund — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Morgan Stanley Direct Lending Fund filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
3.1%
Return on Assets
Net income ÷ assets
1.24x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $122.09M Feb 26, 2026
FY2025 Dec 31, 2024 $215.56M Feb 26, 2026
FY2025 Dec 31, 2023 $231.01M Feb 26, 2026
FY2024 Dec 31, 2022 $48.54M Feb 27, 2025
FY2023 Dec 31, 2021 $83.26M Mar 1, 2024

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.92B Feb 26, 2026
FY2025 Dec 31, 2024 $3.91B Feb 26, 2026
FY2024 Dec 31, 2023 $3.31B Feb 27, 2025
FY2023 Dec 31, 2022 $2.99B Mar 1, 2024

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.17B Feb 26, 2026
FY2025 Dec 31, 2024 $2.07B Feb 26, 2026
FY2024 Dec 31, 2023 $1.59B Feb 27, 2025
FY2023 Dec 31, 2022 $1.59B Mar 1, 2024

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.75B Feb 26, 2026
FY2025 Dec 31, 2024 $1.84B Feb 26, 2026
FY2025 Dec 31, 2023 $1.72B Feb 26, 2026
FY2025 Dec 31, 2022 $1.40B Feb 26, 2026
FY2024 Dec 31, 2021 $1.19B Feb 27, 2025
FY2023 Dec 31, 2020 $301.62M Mar 1, 2024

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 26, 2026
FY2025 Dec 31, 2024 2 Feb 26, 2026
FY2025 Dec 31, 2023 3 Feb 26, 2026
FY2024 Dec 31, 2022 0 Feb 27, 2025
FY2023 Dec 31, 2021 2 Mar 1, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 26, 2026
FY2025 Dec 31, 2024 2 Feb 26, 2026
FY2025 Dec 31, 2023 3 Feb 26, 2026
FY2024 Dec 31, 2022 0 Feb 27, 2025
FY2023 Dec 31, 2021 2 Mar 1, 2024

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $81.43M Feb 26, 2026
FY2025 Dec 31, 2024 $63.40M Feb 26, 2026
FY2024 Dec 31, 2023 $69.71M Feb 27, 2025
FY2023 Dec 31, 2022 $81.22M Mar 1, 2024

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.09B Feb 26, 2026
FY2025 Dec 31, 2024 $1.97B Feb 26, 2026
FY2024 Dec 31, 2023 $1.50B Feb 27, 2025
FY2023 Dec 31, 2022 $1.52B Mar 1, 2024